Followers | 145 |
Posts | 27714 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Sunday, March 07, 2021 3:22:34 AM
By Linda Haig -March 6, 2021
https://marketingsentinel.com/2021/03/06/12-month-price-target-for-biondvax-pharmaceuticals-ltd-nasdaqbvxv-now-sits-at-30/
Wall Street analysts have assigned a consensus price target of $30 to the stock, which implies a rise of 728.73% to its current value. Analysts have been projecting $30 as a low price target for the stock while placing it at a high target of $30. It follows that stock’s current price would jump +728.73% in reaching the projected high whereas dropping to the targeted low would mean a loss of 728.73% for stock’s current value.
LOL, I wish
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM